Prime Medicine, Inc. (PRME)
3.33
+0.04
(+1.22%)
USD |
NASDAQ |
Feb 19, 16:00
3.30
-0.03
(-0.90%)
Pre-Market: 08:55
Prime Medicine EPS Diluted (Quarterly) : -0.3152 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Vanda Pharmaceuticals, Inc. | -2.389 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.58M |
| Revenue (Quarterly) | 1.225M |
| Total Expenses (Quarterly) | 51.81M |
| Enterprise Value | 505.95M |
| Gross Profit Margin (Quarterly) | -53.55% |
| Profit Margin (Quarterly) | -4.13K% |
| Earnings Yield | -44.30% |
| Normalized Earnings Yield | -44.25 |